Ubs Group Ag Elanco Animal Health Inc Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Ubs Group Ag holds 4,165,279 shares of ELAN stock, worth $45.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,165,279

Previous 50,000 8230.56%

Holding current value

$45.9 Million

Previous $734,000 6772.07%

% of portfolio

0.01%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$11.63 - $14.67 $26.7 Million - $33.7 Million	2,294,012 Added 122.59%	4,165,279 $50.4 Million
Q3 2024 Nov 14, 2024	SELL	$11.85 - $15.47 $478,668 - $624,895	-40,394 Reduced 2.11%	1,871,267 $27.5 Million
Q2 2024 Aug 13, 2024	BUY	$12.93 - $18.45 $9.29 Million - $13.3 Million	718,850 Added 60.27%	1,911,661 $27.6 Million
Q1 2024 May 13, 2024	BUY	$14.37 - $16.46 $1.09 Million - $1.24 Million	75,615 Added 6.77%	1,192,811 $19.4 Million
Q4 2023 Feb 09, 2024	BUY	$8.6 - $14.94 $3.74 Million - $6.5 Million	435,291 Added 63.83%	1,117,196 $16.6 Million
Q3 2023 Nov 09, 2023	BUY	$9.81 - $12.62 $2.93 Million - $3.78 Million	299,166 Added 78.16%	681,905 $7.66 Million
Q2 2023 Aug 11, 2023	BUY	$8.08 - $10.37 $1.25 Million - $1.61 Million	155,203 Added 68.21%	382,739 $3.85 Million
Q1 2023 May 12, 2023	SELL	$8.79 - $14.58 $3 Million - $4.98 Million	-341,402 Reduced 60.01%	227,536 $2.14 Million
Q4 2022 Feb 08, 2023	BUY	$11.49 - $13.65 $4.29 Million - $5.1 Million	373,337 Added 190.87%	568,938 $6.95 Million
Q3 2022 Nov 10, 2022	BUY	$12.41 - $32.42 $349,142 - $912,104	28,134 Added 16.8%	195,601 $2.43 Million
Q2 2022 Aug 10, 2022	SELL	$19.63 - $26.62 $1 Million - $1.36 Million	-51,138 Reduced 23.39%	167,467 $3.29 Million
Q1 2022 May 16, 2022	SELL	$24.65 - $29.0 $917,818 - $1.08 Million	-37,234 Reduced 14.55%	218,605 $5.7 Million
Q4 2021 Feb 14, 2022	SELL	$27.74 - $34.09 $39.8 Million - $48.9 Million	-1,433,714 Reduced 84.86%	255,839 $7.26 Million
Q3 2021 Nov 15, 2021	BUY	$29.2 - $36.72 $14.3 Million - $18 Million	490,239 Added 40.88%	1,689,553 $53.9 Million
Q2 2021 Aug 13, 2021	BUY	$28.76 - $35.98 $11.1 Million - $13.8 Million	384,875 Added 47.26%	1,199,314 $41.6 Million
Q1 2021 May 12, 2021	BUY	$27.85 - $34.49 $6.15 Million - $7.61 Million	220,771 Added 37.19%	814,439 $24 Million
Q4 2020 Feb 11, 2021	SELL	$27.53 - $33.79 $332 Million - $407 Million	-12,057,629 Reduced 95.31%	593,668 $18.2 Million
Q3 2020 Nov 12, 2020	BUY	$21.1 - $29.13 $33.9 Million - $46.7 Million	1,604,867 Added 14.53%	12,651,297 $353 Million
Q2 2020 Jul 31, 2020	BUY	$18.94 - $24.93 $201 Million - $264 Million	10,598,327 Added 2365.15%	11,046,430 $237 Million
Q1 2020 May 01, 2020	SELL	$16.68 - $32.25 $3.05 Million - $5.9 Million	-183,090 Reduced 29.01%	448,103 $10 Million
Q4 2019 Feb 14, 2020	BUY	$25.29 - $29.45 $4.82 Million - $5.61 Million	190,657 Added 43.28%	631,193 $18.6 Million
Q3 2019 Nov 14, 2019	SELL	$25.62 - $34.96 $7.32 Million - $9.99 Million	-285,826 Reduced 39.35%	440,536 $11.7 Million
Q2 2019 Aug 14, 2019	BUY	$31.11 - $34.79 $9.92 Million - $11.1 Million	318,787 Added 78.22%	726,362 $24.6 Million
Q1 2019 May 14, 2019	BUY	$29.0 - $32.83 $11.6 Million - $13.1 Million	399,949 Added 5244.54%	407,575 $13.1 Million
Q4 2018 Feb 14, 2019	SELL	$29.63 - $34.5 $33,837 - $39,399	-1,142 Reduced 13.02%	7,626 $241,000
Q3 2018 Nov 14, 2018	BUY	$34.1 - $36.19 $298,988 - $317,313	8,768 New	8,768 $306,000

Others Institutions Holding ELAN

# of Institutions

438

Shares Held

448M

Call Options Held

1.16M

Put Options Held

1.12M

View Full List

About Elanco Animal Health Inc

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.22B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

More about ELAN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account